Carbidopa and Levodopa Extended-Release Tablets and Pramlintide Subcutaneous
Determining the interaction of Carbidopa and Levodopa Extended-Release Tablets and Pramlintide Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: carbidopa / levodopa
Brand name: Parcopa, Rytary, Sinemet, Sinemet CR, Duopa
Synonyms: Carbidopa and levodopa, Carbidopa and Levodopa
Generic Name: pramlintide
Brand name: SymlinPen 120, SymlinPen 60, Symlin
Synonyms: Pramlintide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Carbidopa and Levodopa Extended-Release Tablets-Pramosone
- Carbidopa and Levodopa Extended-Release Tablets-Pramosone Cream
- Carbidopa and Levodopa Extended-Release Tablets-Pramosone E Cream
- Carbidopa and Levodopa Extended-Release Tablets-Pramosone Ointment
- Carbidopa and Levodopa Extended-Release Tablets-Pramoxine and Hydrocortisone
- Carbidopa and Levodopa Extended-Release Tablets-Pramoxine and Hydrocortisone Cream, Gel, and Ointment
- Pramlintide Subcutaneous-Carbidopa and Levodopa ODT
- Pramlintide Subcutaneous-Carbidopa and Levodopa Orally Disintegrating Tablets
- Pramlintide Subcutaneous-Carbidopa and levodopa Route Not Applicable
- Pramlintide Subcutaneous-Carbidopa and Levodopa Tablets
- Pramlintide Subcutaneous-Carbidopa Tablets
- Pramlintide Subcutaneous-Carbidopa, entacapone, and levodopa